← Back to all trials
Active Not Recruiting
NCT05360849
Implementing PrEP for Women Who Inject Drugs
Conditions: HIV, Intravenous Substance Abuse, Women's Health, Organization and Administration, Primary Prevention, Implementation Science
Sex: Female
Ages: 18 Years – N/A
Healthy volunteers: Yes
Phase: NA
Enrollment: 130
Sponsor: University of Pennsylvania
Location: University of Pennsylvania School of Nursing Philadelphia Pennsylvania
Summary
Women who inject drugs are among the most vulnerable to acquiring HIV, but very few women who inject drugs are prescribed pre-exposure prophylaxis (PrEP) for HIV prevention largely due to barriers within our healthcare system. This research will consider the perspectives of women who inject drugs, healthcare providers, and clinic leadership to improve the way primary care and reproductive health clinics deliver PrEP to women who inject drugs, thereby reducing new HIV infections in this population.
Eligibility Criteria
Inclusion Criteria:
To be included in the pilot test of Practice Facilitation, clinics must:
* Complete prior leadership and provider surveys
* Have 50 or more clinic visits with women who inject drugs in the past year
* Have 3 or more clinicians who provide primary and/or reproductive healthcare
* Have leadership willing to participate
Exclusion Criteria:
* None
Source: ClinicalTrials.gov (NCT05360849). StuddyBuddy aggregates publicly available trial information.
